Cidara Therapeutics

About Cidara Therapeutics

Cidara Therapeutics (“Cidara”) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives that have the potential to transform the standard of care and save or improve patients' lives. Our lead product candidate, rezafungin, is a novel antifungal drug being developed for the treatment and prevention of life-threatening fungal infections. In addition, Cidara is applying its proprietary Cloudbreak® immunotherapy technology platform to develop novel drugs for the universal prevention and treatment of influenza and other viral diseases.

Regional Employees
San Diego, CA
We're Hiring!

More about Cidara Therapeutics